TOKYO: AstraZeneca Plc and Daiichi Sankyo Co Ltd signed a deal to develop and sell Daiichi's cancer drug trastuzumab deruxtecan that could see the British drugmaker pay as much as US$6.9 billion to its Japanese partner.
Daiichi is the latest Japanese drugmaker to strike such a deal to gain access to a bigger overseas player's R&D and sales clout.
Source: Healthcare Press (healthcarepress.net)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Daiichi Sankyo, AstraZeneca sign US$6.9 billion cancer drug dealAstraZeneca Plc and Japan's Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi's cancer ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US jury says Bayer must pay US$81 million to man in Roundup cancer trialA U.S. jury on Wednesday awarded US$80.9 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US jury says Bayer must pay US$81m to man in Roundup cancer trialA U.S. jury on Wednesday awarded US$80.9 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
EU approves AstraZeneca's drug for adjunct use in Type-1 diabetesREUTERS: British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Uber could announce US$3 billion deal with Careem early this week: sourcesUber Technologies Inc is set to offer over US$3 billion to buy Dubai-based rival Careem Networks FZ, two sources familiar with the deal told Reuters.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Business chiefs deny US$5 billion fraud over HP-Autonomy dealLONDON: Bosses at a UK software firm, Autonomy, have denied committing fraud to inflate its value before selling the group to US tech giant ... + you've to rewire their shit all the time but you always forget when the computer is off so you're stuck with a crappy unit.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
UPS eyes in-home health services with US vaccine projectUnited Parcel Service Inc wants to get beyond U.S. doorsteps with a new push into healthcare.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
HSA recalls three brands of high blood pressure drug losartan over cancer riskSINGAPORE - Three brands of a medicine prescribed for high blood pressure are being recalled because they contain higher than acceptable amounts of nitrosamine impurity, which can potentially cause cancer.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
HSA recalls 3 brands of high blood pressure drug over cancer riskSingapore — The Health Sciences Authority (HSA) has recalled three brands of high blood pressure medicines that contain the ingredient losartan as the drugs contain higher than acceptable levels of a potentially harmful impurity, said the authority on Thursday (March 28).
Source: TODAYonline - 🏆 1. / 99 Read more »
Uber buys rival Careem in $3.1 billion deal to dominate ride-hailing in Middle EastSAN FRANCISCO/DUBAI (Reuters) - Global ride-hailing firm Uber Technologies Inc will spend $3.1 billion to acquire Middle East rival Careem, buying dominance in a competitive region ahead of a hotly anticipated initial public offering. Uber said late on Monday night it would pay $1.4 billion in cash For the rich and elite Wrong link, sis.
Source: YahooSG - 🏆 3. / 71 Read more »